Analyst Ratings For SOC Telemed
SOC Telemed (NASDAQ:TLMD) has observed the following analyst ratings within the last quarter:
Credit Suisse Maintains Neutral on SOC Telemed, Raises Price Target to $3
Credit Suisse analyst Jailendra Singh maintains SOC Telemed (NASDAQ:TLMD) with a Neutral and raises the price target from $2 to $3.
Top 10 Trending Penny Stocks for Friday, Feb. 4, 2022 (Sentiment via Swaggy Stocks)
SOC Telamed (TLMD)
Exela Technologies (XELA)
Senseonics (SENS)
Applied Genetic Technologies (AGTC)
Reed's (REED)
Citius Pharmaceuticals (CTXR)
OceanPal (OP)
Exicure (XCUR)
Veru (VERU)
Gran Tierra Energy
Benchmark Downgrades SOC Telemed to Hold
Benchmark analyst Bill Sutherland downgrades SOC Telemed (NASDAQ:TLMD) from Buy to Hold.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows.